Bcl-2 is a critical mediator of intestinal transformation
The anti-apoptotic protein Bcl-2 is selectively expressed in intestinal stem cells (ISCs). Here, the authors show that, in intestinal stem cells, Bcl-2 alleviates apoptotic priming induced by the loss of the tumour suppressor Apc in ISCs and that the absence of Bcl-2 or pharmacological blockade of B...
Guardado en:
Autores principales: | Maartje van der Heijden, Cheryl D. Zimberlin, Anna M. Nicholson, Selcuk Colak, Richard Kemp, Sybren L. Meijer, Jan Paul Medema, Florian R. Greten, Marnix Jansen, Douglas J. Winton, Louis Vermeulen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/79fa743e4cb74ee29cb645e41f5d7283 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models
por: Juliusz Mieszczanek, et al.
Publicado: (2019) -
Computational Genomics of Specialized Metabolism: from Natural Product Discovery to Microbiome Ecology
por: Marnix H. Medema
Publicado: (2018) -
CD44 expression in intestinal epithelium and colorectal cancer is independent of p53 status.
por: Jurrit Zeilstra, et al.
Publicado: (2013) -
BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.
por: Elizabeth T Wiles, et al.
Publicado: (2013) -
Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
por: Reut Yosef, et al.
Publicado: (2016)